Dexfenfluramine in obesity [Briefing note]
Scottish Health Purchasing Information Centre
Record ID 31999008488
English
Authors' objectives:
To examine the overall costs and benefits of dexfenfluramine in obesity.
Authors' recommendations:
Dexfenfluramine treatment for periods of a year or less does not seem worthwhile, because the weight is replaced when the drug is stopped. Because of lack of evidence regarding long-term safety, it cannot be recommended for long term use.
We therefore do not think dexfenfluramine is a cost-effective treatment for obesity.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.nhsconfed.net/shpic/doc09.htm
Year Published:
1997
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Costs and Cost Analysis
- Fenfluramine
- Appetite Depressants
- Obesity
Contact
Organisation Name:
Scottish Health Purchasing Information Centre
Copyright:
Scottish Health Purchasing Information Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.